Invention Grant
- Patent Title: FC engineered anti-TNFR superfamily member antibodies having enhanced agonistic activity and methods of using them
-
Application No.: US16840830Application Date: 2020-04-06
-
Publication No.: US11359029B2Publication Date: 2022-06-14
- Inventor: Mark Chiu , Di Zhang
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Kirk Baumeister
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present invention relates to engineered anti-TNFR superfamily member antibodies having enhanced agonistic activity and methods of using them.
Public/Granted literature
Information query
